Key result
Oral administration of the renin inhibitor ES-8891 for 1 week decreased kidney renin mRNA content compared to normal controls.
Why the study?
Does the renin inhibitor ES-8891 reduce renin synthesis and secretion in normotensive sodium-depleted marmosets?
Does the renin inhibitor ES-8891 reduce renin synthesis and secretion in normotensive sodium-depleted marmosets?
In a marmoset model, the renin inhibitor ES-8891 decreased both plasma renin activity and kidney renin synthesis.
Answers are grounded in this paper and cite their sources.
Supports mechanism in marmoset model; leaves open human translation and efficacy trials.
The effects of renin inhibitor ES-8891 on renin synthesis and its secretion by the kidney were investigated in normotensive sodium-depleted marmosets. We measured plasma renin activity, plasma immunoreactive renin concentration, plasma angiotensin II concentration and kidney renin mRNA content after oral administration of ES-8891 (60 mg day-1 kg-1) for 1 week. 2. The mean blood pressure was significantly decreased (P less than 0.01) on day 7 after oral administration of ES-8891. There was no significant change in heart rate during the administration. 3. Oral administration of ES-8891 for 1 week markedly decreased the plasma renin activity, the plasma immunoreactive renin concentration and the plasma angiotensin II concentration (to 18%, 41% and 24% of the corresponding control values; P less than 0.05 for each, n = 5). 4. The kidney renin mRNA content in ES-8891-treated marmosets was significantly lower than that in normal controls (4.2 +/- 3.5 versus 12.8 +/- 5.5 pg/micrograms of total RNA, means +/- SD, P less than 0.05, n = 5). 5. Oral administration of the renin inhibitor ES-8891 for 1 week not only inhibited plasma renin activity but also decreased renin synthesis and its secretion by the kidney.
No takes yet. Share an insight, caveat, or question.
Kitami et al. (1991) studied Normotensive sodium-depleted (n=10). ES-8891 vs. Normal controls was evaluated on Kidney renin mRNA content (pg/micrograms of total RNA) (p=<0.05). Oral administration of the renin inhibitor ES-8891 for 1 week decreased kidney renin mRNA content compared to normal controls.
Synapse has enriched 10 related papers. Consider them for comparative context: